---
category: news
title: "Gilead’s remdesivir receives exceptional approval in Japan for COVID-19"
excerpt: "Just days after Foster City, Calif.-based Gilead Sciences Inc. gained emergency use authorization (EUA) from the FDA for antiviral Veklury (remdesivir) for the treatment of patients with SARS-CoV-2 infection,"
publishedDateTime: 2020-05-07T23:15:00Z
webUrl: "https://www.bioworld.com/articles/434933-gileads-remdesivir-receives-exceptional-approval-in-japan-for-covid-19"
type: article
quality: 55
heat: 55
published: false

provider:
  name: BioWorld
  domain: bioworld.com

topics:
  - Treatment
  - Coronavirus

images:
  - url: "https://www.bioworld.com/ext/resources/BMT-source/2020/4-28-Aytu-cedars-sinai-main-building.png?height=355&t=1588111273&width=640"
    width: 473
    height: 355
    title: "Gilead’s remdesivir receives exceptional approval in Japan for COVID-19"

secured: "lBHi/u2+oWi2+hS/p9n1SPr7lCkzZNg2OOQwh1LKAVyThr5pNNdmnlNSqvq63mf++WahbNjIaHj72bB++aIMW68ueTEHxNu7P1LynTqmD2nYPgjAKCH2hXiE9LB0TkSIbzBT6g40ILfAchJgSQK+LSe/geHZ9kWXhgeWOl08Hc8DT097Vt1+NfuyQMyK5A1n4s6VusMubYZRW6CCEuXZIyvXiAokHE9zXx5PuY9Mjb1U4GVy5i5xi2ldfBCFCpVF+WQhbr/+N743fhm9JOFSnwsr6yJgDXi9qIakVo9kpfw8dgSCcBSlVt3R6ikABqEL;zuZ677mN0yv3YVHLIgdl2g=="
---

